Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic TargetsNicola Antonio di Meo, Giuseppe Lucarelli, Riccardo Autorino et al.|International Journal of Molecular Sciences|2022Cited by 190
Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder CancerNicola Antonio di Meo, Giuseppe Lucarelli, Davide Loizzo et al.|International Journal of Molecular Sciences|2022Cited by 61
Novel Insights into Autophagy and Prostate Cancer: A Comprehensive ReviewDavide Loizzo, Giuseppe Lucarelli, Savio Domenico Pandolfo et al.|International Journal of Molecular Sciences|2022Cited by 59
Long-term outcomes in ypT0 rectal cancers: An international multi-centric investigation on behalf of Italian Society of Surgical Oncology Young Board (YSICO)Laura Lorenzon, Dario Parini, Daniela Rega et al.|European Journal of Surgical Oncology|2017Cited by 15
Pathologic stage of ypT0N+ rectal cancers following neo-adjuvant treatment: clinical interpretation of an orphan statusLaura Lorenzon, Stefano Mancini, Raffaele De Luca et al.|Pathology - Research and Practice|2022Cited by 3